[HTML][HTML] Protective effects of APOE e2 against disease progression in subcortical vascular mild cognitive impairment patients: A three-year longitudinal study

YJ Kim, SW Seo, SB Park, JJ Yang, JS Lee, J Lee… - Scientific reports, 2017 - nature.com
Although the association between apolipoprotein E (APOE) genotype and disease
progression is well characterized in patients with Alzheimer's disease, such a relationship is …

Effects of APOE ɛ4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment

HJ Kim, BS Ye, CW Yoon, H Cho, Y Noh, GH Kim… - Neurobiology of …, 2013 - Elsevier
The relationship between the apolipoprotein E ɛ4 allele (APOE4) and factors associated
with vascular cognitive impairment (VCI) is unclear. We aimed to examine the effects of …

Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment

G Viticchi, L Falsetti, F Vernieri… - Journal of …, 2014 - content.iospress.com
The presence of apolipoprotein E (APOE) ε4 allele is the only recognized genetic risk factor
for the sporadic form of Alzheimer's disease. The aim of this study was to investigate the …

[HTML][HTML] MRI markers of small vessel disease and the APOE allele in cognitive impairment

M Shams, S Shams, J Martola, L Cavallin… - Frontiers in Aging …, 2022 - frontiersin.org
OBJECTIVE The apolipoprotein E (APOE) ε4 allele is the main genetic risk factor for
dementia and Alzheimer's disease (AD), but the underlying mechanism for the increased …

[HTML][HTML] Associations between APOE genotype and cerebral small-vessel disease: a longitudinal study

X Luo, Y Jiaerken, X Yu, P Huang, T Qiu, Y Jia, K Li… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Objective It remains unclear if and how the interactions between APOE genotypes and
cerebral small-vessel diseases (CSVD) lead to cognitive decline in the long term. Based on …

Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease

L Traykov, AS Rigaud, L Caputo… - European Journal of …, 1999 - Wiley Online Library
Controversy exists regarding the apolipoprotein E (ApoE) ɛ4 allele association with
vascular dementia (VaD), ranging from increased ɛ4 frequency, similar to that found for …

Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes

RJ Caselli, AC Dueck, DEC Locke, MN Sabbagh… - Neurology, 2011 - AAN Enterprises
Objective: To characterize the effects of cerebrovascular (CV) risk factors on preclinical
memory decline in cognitively normal individuals at 3 levels of genetic risk for Alzheimer …

APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline

KJ Bangen, A Beiser, L Delano-Wood… - Journal of Stroke and …, 2013 - Elsevier
Background Vascular risk factors have been associated with cognitive decline; however, it
remains unclear whether apolipoprotein E (APOE) genotype modifies this relationship. We …

Apolipoprotein E ε4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease

L Traykov, AS Rigaud, S Baudic, A Smagghe… - Journal of the …, 2002 - Elsevier
Controversy exists regarding the apolipoprotein E (ApoE) ε4 allele association with vascular
dementia (VaD). The results range from increased ε4 frequency, similar to that found for …

APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults

M Lamar, L Yu, LH Rubin, BD James, LL Barnes… - Alzheimer's & …, 2019 - Elsevier
Abstract Introduction Apolipoprotein E (APOE) is a susceptibility gene for late-onset
Alzheimer's disease neuropathology; less is known about the relationship between APOE …